Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
This grant funds multidisciplinary teams to develop and validate biomarkers and imaging tools for early detection of pancreatic cancer and its precursors, focusing on high-risk individuals and collaborative research.
Browse similar grants
Funder: National Institutes of Health
Due Dates: November 5, 2029 (Closing date)
Funding Amounts: Award ceiling: $600,000
Summary: Supports multidisciplinary research units developing and testing methods for early detection of pancreatic cancer and its precursor lesions.
Key Information: Foreign organizations and foreign components are not eligible.
Description
The National Cancer Institute (NCI) seeks Research Units for the Pancreatic Cancer Detection Consortium through this NIH cooperative agreement. The units will study early detection of pancreatic ductal adenocarcinoma (PDAC) and characterize precursor lesions to identify people at high risk of progression to cancer. The work includes developing and testing molecular and imaging biomarkers, approaches to screening high-risk populations, computational methods for biomarker discovery or validation, and biomarker validation studies.
Research Units will be multidisciplinary teams. They will collect longitudinal biospecimens for a biorepository and collaborate with other units by sharing ideas, biospecimens, and data within the consortium.
